DLB
DOLBY LABORATORIES, INC.Marquee-fund ownership over time
This quarter's activity
New positions opened
None.
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Citadel Advisors | Q3 2024(8Q snapshot) | 7Q | $67 | $54 | -19% |
| D.E. Shaw re-entered | Q3 2024(8Q snapshot) | 7Q | $67 | $54 | -19% |
| AQR Capital Management | Q3 2024(8Q snapshot) | 7Q | $67 | $54 | -19% |
| Millennium Management | Q3 2024(8Q snapshot) | 7Q | $67 | $54 | -19% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Bridgewater Associates 3× in & out | Q3 2025 | Q2 2026 | → $54 | -25% |
| Point72 Asset Management 2× in & out | Q1 2026 | Q2 2026 | → $54 | -14% |
| Renaissance Technologies | Q2 2025 | Q1 2026 | → $66 | -12% |
| Two Sigma Investments | Q4 2024 | Q2 2025 | → $76 | +7% |
| Maverick Capital 3× in & out | Q4 2023 | Q3 2024 | → $67 | -20% |
| Coatue Management | Q1 2020 | Q2 2020 | → $49 | -26% |
Insider activity
Form 4 — officers, directors, 10%+ ownersFiled within two business days of each transaction by anyone with material insider status at Dolby Laboratories, Inc.. Pair with the holders table above as a sanity check: heavy insider buying alongside marquee-fund accumulation is the strongest accumulation signal; heavy insider selling alongside fund exits is the strongest distribution signal.
30d / 90d windows measured from Jun 3, 2026 — the most recent Form 4 on file — not from today.
- Form 40001193125-26-255624Jun 3, 2026
- Form 40001193125-26-242141May 27, 2026
- Form 40001193125-26-231170May 19, 2026
- Form 40001193125-26-224607May 14, 2026
- Form 40001193125-26-209338May 6, 2026
- Form 40001193125-26-142335Apr 3, 2026
- Form 40001193125-26-083094Feb 27, 2026
- Form 40001193125-26-055277Feb 17, 2026
- Form 40001193125-26-055254Feb 17, 2026
- Form 40001193125-26-051551Feb 13, 2026
- Form 40001193125-26-042838Feb 9, 2026
- Form 40001193125-26-039913Feb 5, 2026
- Form 40001193125-26-039911Feb 5, 2026
- Form 40001193125-26-039907Feb 5, 2026
- Form 40001193125-26-039904Feb 5, 2026
Fundamentals
XBRL · DOLBY LABORATORIES, INC.Annual figures sourced directly from DOLBY LABORATORIES, INC.'s 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for Dolby Laboratories, Inc. — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 10-QQuarterly reportApr 30, 2026
- 8-KMaterial eventApr 30, 2026
- 8-KMaterial eventFeb 6, 2026
- 10-QQuarterly reportJan 29, 2026
- 8-KMaterial eventJan 29, 2026
- DEF 14AProxy statementDec 16, 2025
- 10-KAnnual reportNov 18, 2025
- 8-KMaterial eventNov 18, 2025
- 8-KMaterial eventNov 14, 2025
- 10-QQuarterly reportJul 31, 2025
- 8-KMaterial eventJul 31, 2025
- 10-QQuarterly reportMay 1, 2025
- 8-KMaterial eventMay 1, 2025
- 8-KMaterial eventFeb 7, 2025
- 10-QQuarterly reportJan 30, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| D.E. Shaw | Q1 2026 | open | $63 | $54 | -14% |
| Point72 Asset Management | Q1 2026 | Q2 2026 | $63 | $54 | -14% |
| Bridgewater Associates | Q3 2025 | Q2 2026 | $72 | $54 | -25% |
| Renaissance Technologies | Q2 2025 | Q1 2026 | $75 | $66 | -12% |
| Point72 Asset Management | Q1 2025 | Q2 2025 | $82 | $76 | -7% |
| Two Sigma Investments | Q4 2024 | Q2 2025 | $71 | $76 | +7% |
| Bridgewater Associates | Q3 2024 | Q2 2025 | $67 | $75 | +12% |
| Citadel Advisors | Q3 2024 | open | $67 | $54 | -19% |
| D.E. Shaw | Q3 2024 | Q3 2025 | $67 | $71 | +6% |
| AQR Capital Management | Q3 2024 | open | $67 | $54 | -19% |
| Millennium Management | Q3 2024 | open | $67 | $54 | -19% |
| Maverick Capital | Q4 2023 | Q3 2024 | $84 | $67 | -20% |
| Maverick Capital | Q1 2023 | Q3 2023 | $79 | $74 | -6% |
| Bridgewater Associates | Q2 2022 | Q2 2023 | $70 | $80 | +13% |
| Maverick Capital | Q4 2020 | Q2 2022 | $82 | $70 | -14% |
| Coatue Management | Q1 2020 | Q2 2020 | $66 | $49 | -26% |
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.